Sponsors (4)
The resolution raises awareness of ALS—especially delayed diagnosis and elevated veteran risk—which may spur research and policy attention, but it does not allocate funding or guarantee equitable action, so patients' financial and care burdens are largely unchanged.
People with ALS and their caregivers would gain greater federal recognition of ALS's burden, increasing the likelihood of more research attention and supportive services.
People with ALS could benefit from attention to delayed diagnosis (average >1 year), increasing the chance of policies or programs to improve earlier detection, referral, and timelier access to care.
U.S. military veterans could receive targeted attention because of higher ALS diagnosis rates among veterans, potentially improving veteran-specific outreach, screening, and services.
People with ALS and their caregivers still face substantial out-of-pocket medical and home care costs because the resolution recognizes problems but does not provide funding for treatments or support services.
Patients and families may be frustrated as the resolution raises expectations for policy action or cures but does not commit federal resources or concrete policy changes.
Emphasizing higher veteran risk without accompanying equitable policy measures could create perceptions of unequal prioritization, generating tension between veterans and other affected groups.
Based on analysis of 1 section of legislative text.
Records findings about ALS to raise awareness of its scope, impacts on patients and caregivers, and elevated risk among veterans.
Official title: Designating May 2026 as "ALS Awareness Month".
Introduced May 21, 2026 by Christopher A. Coons · Last progress June 3, 2026
Directs attention to amyotrophic lateral sclerosis (ALS) by stating facts about the disease: it is a progressive neurodegenerative disorder that destroys motor neurons, typically leads to death from respiratory failure within 2–5 years after diagnosis, and currently has no cure. The resolution highlights diagnosis delays, the mix of sporadic and genetic causes, the heavy care and cost burdens on patients and families, the elevated risk among U.S. military veterans, and the estimated number of Americans living with or newly diagnosed with ALS each year.